2015 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013 | 2012
Auris Medical Announces Enrollment of First Patient in HEALOS Study of AM-111 in Treatment of Idiopathic Sudden Sensorineural Hearing Loss
13 November 2015
Auris Medical AG : Auris Medical Holding AG Reports Third Quarter 2015 Financial Results and Provides Business Update
12 November 2015
Auris Medical to Announce Third Quarter 2015 Financial Results and Host Conference Call on Thursday, November 12, 2015
05 November 2015
Auris Medical and King's College London Collaborate in Drug Discovery for Second Generation Tinnitus Treatment
23 October 2015
Auris Medical to Host Corporate Symposium on Rational Pharmacotherapy for Acute Hearing Loss on September 28, 2015
25 September 2015
Auris Medical to Present at the Leerink Partners 4th Annual Rare Disease Roundtable on Wednesday, September 30, 2015
23 September 2015
Auris Medical Holding AG Reports Second Quarter 2015 Financial Results and Provides Business Update
19 August 2015
Auris Medical to Announce Second Quarter 2015 Financial Results and Host Conference Call on Wednesday, August 19, 2015
12 August 2015
Auris Medical Promotes Anne Sabine Zoller to General Counsel
03 August 2015
Nasdaq CEO Signature Series Interview with Auris Medical’s CEO
23 July 2015
Auris Medical Holding AG Provides Update on U.S. Intellectual Property Portfolio
02 July 2015
Auris Medical and Cochlear to Collaborate on Clinical Trial with AM-111 for Otoprotection during Cochlear Implant Surgery
25 June 2015
Auris Medical to Present at the JMP Securities Life Sciences Conference 2015 on Wednesday, June 24
17 June 2015
Auris Medical to Present at the Jefferies 2015 Global Healthcare Conference on Tuesday, June 2
02 June 2015
Auris Medical Holding AG Reports First Quarter 2015 Financial Results and Provides Business Update
28 May 2015
Auris Medical to Announce First Quarter 2015 Financial Results and Host Conference Call on Thursday, May 28, 2015
22 May 2015
Auris Medical Holding AG Announces Closing of Public Offering of Common Shares
20 May 2015
Auris Medical Holding AG Announces Notice of Allowance from USPTO Related to Treating Middle Ear Diseases with Poloxamer-Based Fluoroquinolone Compositions
18 May 2015
Auris Medical Holding AG Announces Pricing of Public Offering of Common Shares
15 May 2015
Auris Medical Holding AG Announces Proposed Public Offering of Common Shares
04 May 2015
Auris Medical Holding AG Provides Update on Clinical Development Plan for AM-111
04 May 2015
Auris Medical Announces Publications Related to AM-101 in Peer-Reviewed Scientific and Medical Journals
20 April 2015
Auris Medical to Propose Election of Two New Board Members at Forthcoming Annual General Meeting
30 March 2015
Auris Medical Holding AG Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Business Update
19 March 2015
Auris Medical to Announce Fourth Quarter and Full Year 2014 Financial Results and Host Conference Call on Thursday, March 19, 2015
16 March 2015
Auris Medical Announces Recently Granted Patent in India for the Treatment of Tinnitus
13 March 2015
Auris Medical to Host Key Opinion Leader Meeting on Tinnitus Treatments on March 13 in New York City
11 March 2015
Auris Medical Announces Completion of Interim Analysis in Post-Acute Tinnitus Stratum of TACTT3 Trial with AM-101
10 March 2015
Auris Medical Announces Recently Granted Patent in China for the Treatment of Tinnitus
11 February 2015
Auris Medical to present at the Leerink Global Healthcare Conference
04 February 2015
Auris Medical Holding AG Achieves 50% Enrolment Milestone in Post-Acute Tinnitus Stratum of TACTT3 Clinical Trial
14 January 2015